Diltiazem, a benzothiazepine calcium antagonist, is prescribed widely for the treatment of ischaemic heart disease, hypertension and supraventricular arrhythmias. I Overdose with this drug is an infrequent event but there have been at least 27 cases reported in the literature to date. 2 -5 Predictably, the dominant features of the overdose have been bradycardia or complete heart block, and hypotension.
We report the case of an elderly man who ingested a large overdose of diltiazem. Hypotension and oliguria were refractory to conventional therapy with fluid-loading and calcium, glucagon, dopamine and isoprenaline, but responded dramatically to the administration of adrenaline. The case is notable because of the development of pulmonary oedema which was severe and persistent, necessitating intubation and mechanical ventilation. The pharmacokinetics of diltiazem and the two major, active metabolites were examined and related to those after therapeutic doses in the elderly.
CASE HISTORY A 73-year-old, 72-kg man with a history of angina and recurrent depression was admitted to hospital two hours after intentionally ingesting 80 X 60 mg tablets of diltiazem (4.8 g). He had been prescribed a number of other medications, clofibrate, oxazepam, and sulphinpyrazone, but denied taking an excess number of these. Immediately after admission, he vomited a small number of white tablets and was given 50 g activated charcoal in 300 ml 70% sorbitol via a nasogastric tube. Three further doses of charcoal were given at four-hourly intervals. On admission, he was alert but hypotensive (systolic blood pressure, 50 mmHg) and hypothermic (rectal temperature, 33°C). An ECG showed complete heart block with a ventricular rate of 40 beats per minute (bpm). Physical examination was otherwise normal. Immediate investigations included a normal chest X-ray ( Figure I a) , serum creatinine of 0.12 mmol/l (normal range: 0.06-0.11), corrected serum calcium of 2.45 mmol/l (normal range: 2.25-2.6), and serum glucose of 11.1 mmolll (normal range: 3.2-7.5). Blood gases on 25% oxygen were P a o 2 119 mmHg, PaC02 37 mmHg, pH 7.32.
Because of the bradycardia and hypotension, intravenous bolus doses of calcium gluconate (total , and an infusion of dopamine 10 ~glkglmin and normal saline (3000 ml) were given but the vital signs were unaffected. Two-anda-half hours after the ingestion, an external pacemaker was applied. Despite pacing at a rate of 100 bpm, the systolic blood pressure remained less than 60 mmHg. He was transferred to the Coronary Care Unit where a transvenous pacing wire was inserted and the heart rate maintained at 80 bpm. Over the next six hours he received a further four litres of normal saline, two litres of dextrose saline and infusions of dopamine (20 ;.tglkglmin) and calcium gluconate (10%) at 5 mllhour via a peripheral vein. The systolic blood pressure remained less than 70 mmHg and the patient was oliguric (urine flow less than 10 ml/hr). Eight-and-a-half hours after the overdose, the patient was transferred to the Intensive Care Unit (lCU) because of increasingly severe dyspnoea and clinical and radiological (Figure I B) evidence of pulmonary oedema. On 30% oxygen, the Pa02 was 66 mmHg, the PaC02 38 mmHg and the pH 7.18. The systolic blood pressure was 60 mmHg despite pacing at 100 bpm, the hourly urine volume less than 10 ml, and the rectal temperature 34°C ( Figure  2 ). The patient was placed on a warming blanket and intubated and ventilated because of respiratory distress. The hypotension remained refractory to FIGURE le bolus doses of calcium gluconate (10 ml of 10% solution) and glucagon (I mg) and a higher rate of infusion of dopamine (40 ~glkglmin).
Ten hours after the overdose, the rate of the dopamine infusion was reduced to 2.5 ~glkglmin and the calcium gluconate infusion discontinued. A bolus dose of adrenaline (1.0 mg) was given intravenously followed by an infusion (0. min). The blood pressure rose promptly to 130/60 mmHg ( Figure 2 ) and urine production to greater than 100 mllhour. The complete heart block persisted, necessitating continuous pacing. In view of the persisting severe pulmonary oedema, a pulmonary catheter was inserted to assess the haemodynamics. The pulmonary artery wedge pressure (P A WP) was 12 mmHg, the heart rate 1 00 beats per minute (paced rhythm), and the systemic blood pressure, 125/60 mmHg. The PAWP never exceeded 12 mmHg before the catheter was removed 48 hours later. The temperature increased to 37"C over the next eight hours; by 35 hours after the overdose, sinus rhythm had returned. During that time, the blood pressure remained stable on an infusion of adrenaline of 0.2-0.6 ~glkglmin. Therefore, the adrenaline and dopamine infusions were tapered off over the following 18 hours. Serial cardiac enzymes and electrocardiograms showed no evidence of myocardial infarction. Despite residual pulmonary oedema, the patient was extubated four days after admission and was well enough to be discharged to the medical ward. The abnormal chest X-ray findings, which were still persistent on day 6 (Figure 1 C) , resolved slowly over the next few days. Before going home six weeks later, the patient's depression had responded well to electroconvulsive therapy.
Concentrations of diltiazem, N -monodesmethyldiltiazem and deacetyldiltiazem in serial serum samples taken after admission to the ICU were determined by high performance liquid chromatography according to the method of Montamet et al. 6 and are presented in Figure 3 
DISCUSSION
This elderly patient demonstrated typical features of diltiazem overdose, the most severe of which were hypotension with secondary oliguria, complete heart block and hypothermia. The hypotension was unresponsive to cardiac pacing, volume loading, calcium, glucagon and high-dose dopamine, but was responsive to adrenaline. The hypothermia only resolved after the blood pressure had returned to normal. We attribute the action of adrenaline to the combination of the inotropic and peripheral vasoconstrictor effects of the high dose used. Use of dopamine in a higher dose may have been efficacious. However, given the lack of response to the infusion of a relatively high dose of this drug (40 ~glkglmin) over ten hours, the decision was made to change to an alternative agent rather than increase the dose of dopamine. Adrenaline has been reported to be effective for the same indications in one other diltiazem-overdose patient but in that case metoprolol was ingested as well. 9 The complete heart block was unresponsive to atropine, isoprenaline and subsequently adrenaline, but was treated adequately by external cardiac pacing initially until a transvenous pacemaker could be inserted.
Our patient developed severe pulmonary oedema about four hours after admission. This has been reported previously after overdose with verapamil, to nifedipine 11 and diltiazem. 5 The mechanism of the oedema could be cardiogenic, given the fluid load (3 litres) used during the initial period of resuscitation and the myocardial depression produced by diltiazem. Secondly, it could have been non-cardiogenic, as has been reported in another diltiazem overdose patient. 5 Unfortunately, in our patient measurement of the P A WP was delayed until the patient was admitted to the ICU, ten hours after the ingestion. Therefore, distinction between the two types of pulmonary oedema is not possible. It should be noted that the P A WP was also measured late in the other patient, after the oedema had developed. 5 The pharmacokinetic analysis indicated that about 1000 mg of diltiazem were absorbed. Assuming that the history of ingestion of 4.8 g of this drug was correct, this suggests that a substantial amount was lost in the emesis and/or adsorbed by the activated charcoal. Diltiazem should be adsorbed well by charcoal and, according to the serum diltiazem concentration versus time profile in our patient and one other,4 absorption of the drug was complete by about six hours after the overdose. Nevertheless, our patient was given a total off our doses of activated charcoal; the patient of Roberts et al.,4 who ingested a similar dose, received five. In both cases, the' half-life of diltiazem was about twice as long as the mean reported for elderly patients with angina pectoris (6.61 ± 1.97 hr)12 and three times that reported in a group of elderly patients with hypertension. 7 This indicates that the repeated doses of charcoal were unlikely to have increased elimination of absorbed drug. 4 In future, we plan to admit patients who have taken a large overdose of diltiazem to the ICV for full haemodynamic monitoring. Activated charcoal will be used to reduce absorption of diltiazem from the gastrointestinal tract. A single dose of charcoal should suffice to prevent absorption of the drug, unless the product taken is a slow-release formulation or gastric emptying is delayed. Severe hypotension, not responsive to cautious plasma expansion, rewarming, and the administration of calcium will be treated by the infusion of adrenaline titrated to the response. Bradycardia, if not immediately responsive to atropine, or complete heart block will be treated by temporary cardiac pacing.
